| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |